Table 1.

Critical predisposing factors which increase mucormycosis vulnerability.

Blood Associated Malignancies (Lymphoma, Leukemia and Myeloproliferative Disorders)
Uncontrolled diabetes mellitus concurrent with ketoacidosis
High dose corticosteroids/immuno-suppressive drugs for 2–3 weeks
Solid organ malignancies
Solid organ transplantation
Therapy with Deferoxamine
Metabolic acidosis
Hematopoietic stem cell transplantation
Rheumatologic disorders
Multiple transfusions
Neonatal prematurity
Malnutrition
Prophylaxis with voriconazole (breakthrough invasive fungal infections)